Fecal Sand Clearance Is Enhanced with a Product Combining Probiotics, Prebiotics, and Psyllium in Clinically Normal Horses

Consumption of sand and dirt by horses can cause chronic diarrhea, weight loss, and colic caused by irritation and obstruction of the gastrointestinal tract. Prevention has been primarily focused on changes in management to reduce the intake of sand resulting from feeding on the ground. Studies regarding the use of psyllium for the prevention of sand accumulation in clinically normal horses have not been published. A nutritional supplement combining probiotics, prebiotics, and psyllium was hypothesized to increase fecal sand output in clinically normal horses in a natural environment. A measured volume of feces was collected daily from eight clinically normal horses and screened for sand 1 week before and during 35 days of treatment with a supplement combining probiotics, prebiotics, and psyllium. Sand was isolated from feces using a flotation decanting method and was expressed in milligrams sand per gram of feces. Fecal sand output increased significantly (P < .01) by day 4 of supplementation and remained significantly increased through day 31 of the feeding trial. Daily supplementation with a probiotic, prebiotic, and psyllium supplement demonstrated enhanced fecal sand clearance in clinically normal horses. These results suggest that this product may be an effective prophylactic treatment for sand enteropathy and sand colic in which management alone is not sufficient to prevent intestinal sand accumulation. Further studies are needed to confirm the utility of this product in clearing sand from horses with naturally occurring sand impactions and enteropathy.     

Diarrhea associated with sand in the gastrointestinal tract of horses

Four horses with diarrhea had radiographic evidence of large quantities of sand in the gastrointestinal tract. Initially, none of the horses had sufficient fecal sand quantity to suggest sand enteropathy. Diarrhea resolved in all horses within 2 days of oral administration of psyllium hydrophilic mucilloid. Historically, all 4 horses had lost weight or had difficulty maintaining weight. After treatment was administered, the horses either gained weight or were easier to maintain in good condition.     

Abdominal radiography in monitoring the resolution of sand accumulations from the large colon of horses treated medically

This retrospective study consisted of 14 horses (age 6 weeks-12 years) with radiographically evident sand accumulations cranioventrally in the abdomen and clinical signs suggestive of sand enteropathy. The horses were treated medically and resolution of sand was monitored radiographically. Routine treatment consisted of psyllium mucilloid, combined with magnesium sulphate and/or mineral oilif needed. Initially, the number, size and shape of the sand accumulations showed large variation and the response to therapy was not predictable based on the initial appearance of the accumulation. In 2 foals, some of the sand was passed and the rest was mixed with other intestinal contents within 2-4 days. Even large accumulations disappeared in 2-4 days with psyllium alone or combined with mineral oil in 4 horses. In another 4 horses, the size of the accumulations decreased but varying amounts remained approximately at the same site, despite treatment for 1-4 weeks, and all these horses also had either gastric or large colon impaction. Three horses had a limited response to psyllium treatment, but the accumulation resolved with repeated doses of magnesium sulphate, with or without mineral oil. One horse did not respond to prolonged laxative treatment but the accumulation resolved on pasture. Clinical improvement was not necessarily related to the resolution of sand. Radiography of the cranioventral abdomen was found to be a useful means for monitoring the resolution of sand and confirming the effect of medical treatment in removing sand from the large colon in the horse.     

Evacuation of sand from the equine intestine with mineral oil, with and without psyllium

The aim of this study was to determine the evacuation of sand from the equine intestine after a double treatment with psyllium and mineral oil or mineral oil only. A crossover study was conducted. Twelve healthy horses were fed 1 kg sand once a day for 5 days. Subsequently, these horses were divided into two groups: A and B. From day 6-10, both groups were treated with 2 l of mineral oil once a day and group B received an additional 0.5 kg of psyllium twice a day. The trial was repeated after 2 weeks with treatment crossover of groups A and B. The horses were housed sand free and 1.8 kg hay/100 kg body weight was offered to meet the maintenance energy requirement. Prior to the sand administration, faeces were collected from each horse for 3 days and the crude ash was determined to establish a baseline output of ash. There was no difference between the baseline crude ash output of the first and second treatment. From day 6-10, faeces were collected daily and the fresh weight and the dry matter and the crude ash contents were determined. For administration, sand or psyllium was mixed with 1 l of Irish mash (concentrate mixed with water), respectively, and mineral oil was administered via a nasogastric tube. All horses showed higher crude ash excretion when treated with psyllium and mineral oil compared with the mineral oil administration only. On the second, third and fourth day of the treatment, the difference was significant. Faeces crude ash weight corrected for baseline crude ash output while treated with psyllium plus oil and oil solely, reached a mean of 51.0 (SD 20.5) and 26.1 (SD 17.7) % of the administered sand mass, respectively. The results of this trial show that the ash output differed highly between the horses. Nevertheless, all horses showed a higher total ash output within the 5 days treatment period when the psyllium semen and mineral oil were used for the treatment than when treated with mineral oil solely.     

Failure of Psyllium Mucilloid to Hasten Evacuation of Sand From the Equine Large Intestine

Objective —To examine the efficacy of psyllium mucilloid in evacuating sand from the equine large intestine.
Animals —12 clinically healthy pony geldings.
Procedure—Twelve ponies were assigned to 2 groups of six each. One group was treated with psyllium and the second was a control group. All ponies had an exploratory celiotomy and 10 g/kg body weight of sand was placed into the cecum. Ponies were fed a grain mixture alone at 1 g/kg (controls), a grain mixture plus psyllium pellets, each at 1 g/kg body weight (3 ponies), or fed a grain mixture and given psyllium powder by nasogastric tube at 1 g/kg body weight divided into two daily doses in 3 L of water (3 ponies). Radiographs were taken on days 1 (3 per group), 5 (all ponies), and 11 (3 per group) to monitor sand transit through the large intestine. Ponies were euthanatized 11 days after surgery. Sand was collected from the contents of the cecum, ventral colon, dorsal colon, and small colon. Dry weight of the recovered sand was compared between the two treatment groups as a percentage of the dry weight of sand placed in the cecum.
Results —No significant differences were detected in the mean percentage of sand recovered between the two treatment groups ( P < .05), with 39.2% recovered in ponies treated with psyllium and 27.4% recovered in control ponies.
Clinical Relevance —Psyllium mucilloid had no apparent effect on sand evacuation from the equine large intestine. When intake of sand is prevented, the equine large intestine can reduce and possibly eliminate its sand burden.     

Surgical Treatment of Sand Colic Results in 40 Horses

A retrospective study of 40 horses that underwent surgical treatment for sand colic was performed. Three horses were euthanatized and one died during surgery. Of the 36 horses that recovered from anesthesia, five died before discharge from the hospital and seven died after discharge. Twenty-four horses survived at least 12 months. Sand impaction of the right dorsal colon was present in 26 horses. In addition to sand impaction, 10 horses also had colonic displacement or volvulus.     

Abdominal Auscultation in the Detection of Experimentally Induced Gastrointestinal Sand Accumulation

A blind study was designed to determine if abdominal auscultation is an effective method for detecting the presence of intestinal sand. Fifteen horses divided into two groups were used in the study. There were seven horses in Group 1 and eight horses in Group 2. All horses were auscultated and determined to be free of sand sounds before initiation of Trial 1. Group 1 horses were given 4.2 g/kg body weight of sand via nasogastric tube using carboxymethylcellulose (CMC) as a suspending agent at 9.0 ml/kg body weight. Group 2 horses were given CMC only. Horses remained in the same group through all trials. A total of five trails, each lasting 24 hours, was performed. Dosing with sand and CMC or CMC alone was repeated at the beginning of each trial. Abdominal auscultation was performed on each of the 15 horses beginning on Trial 2 by an investigator with no knowledge of the grouping of the horses. The ventral abdomen was auscultated for 5 minutes at 7 hours and 17 hours after trial initiation. When a horse was considered positive for intestinal sand by auscultation, the horse was eliminated from future trials. On Trial 2, no horses were positive; on Trial 3, one horse; on Trial 4, two horses, and on Trial 5, four horses. Sounds considered characteristic for sand in the intestinal tract were eventually identified in all Group 1 horses. No horses in Group 2 were ever identified as having sounds characteristic for intestinal sand at any point during this investigation.     

Reliability of ultrasonography compared to radiography in revealing intestinal sand accumulations in horses

In order to investigate the reliability of ultrasonography in revealing intestinal sand accumulations, the cranioventral parts of the abdomen of 32 horses (age 3-20 years) with signs suggestive of gastrointestinal sand were examined radiographically and ultrasonographically. The amount of sand and its localisation, relative to the ventral abdominal wall, were evaluated radiographically and graded (scale 0-4). Motility of the intestine and whether it was lying against the ventral abdominal wall were evaluated ultrasonographically and the findings summed and graded (scale 0-3) to express the likelihood of the presence of sand. The ultrasonographic and radiographic grades were significantly associated. Out of 14 horses with a moderate or large ventral sand accumulation radiographically, 13 (92.9%) had a positive sand finding ultrasonographically. Out of 8 horses with no signs of sand radiographically, 7 were considered negative for sand ultrasonographically. The specificity of ultrasonography in detecting sand accumulations was 87.5% (7/8) and the sensitivity 87.5% (21/24). Small and more dorsally located accumulations were more difficult to detect ultrasonographically. Of the horses with a small or moderate amount of sand relatively ventrally or only a small part of sand close to the ventral abdominal wall, 70% (7/10) were considered suggestive or positive for sand ultrasonographically. The ventral aspect of sand accumulations was hyperechoic, causing varying acoustic shadowing and the intestine had decreased or absent motility. Ultrasonography revealed the length of the accumulations but gave very limited information of their height. Ultrasonography is a practical and reliable method for detecting sand accumulations but it cannot replace radiography.     

Evaluation of the safety of a combination of oral administration of phenylbutazone and firocoxib in horses

Simultaneous administration of a nonselective COX inhibitor and a COX‐2 specific NSAID has not been previously reported in horses. The goal of this study was to determine the safety of a 10‐day dosage regimen of phenylbutazone and firocoxib, both at their standard dosages, in horses. Six horses were administered 2.2 mg/kg of phenylbutazone and 0.1 mg/kg of firocoxib by mouth, daily for 10 days. Horses were assessed daily for changes in behavior, appetite, fecal consistency, signs of abdominal pain, and oral mucous membrane ulceration. Horses were assessed prior to and on the last day of treatment for changes in serum creatinine, albumin, total protein, and urine‐specific gravity. Horses underwent endoscopic examination of the esophagus, stomach, and pylorus prior to and 24 hours after the last treatment. A significant change in serum creatinine and total protein was observed on day 10 of treatment. No other significant findings were noted during the experiment. Results indicated that co‐administration of phenylbutazone and firocoxib may cause renal disease.     

Inflammatory Response of Healthy Horses Subjected to Small Colon Enterotomy and Treated or Not With Heparin

The acute phase response is a response to injury and depends on the severity of the trauma. Heparin is routinely used for postsurgical treatment of horses to prevent abdominal adhesions; however, its effect on inflammation is unknown. This study aimed to assess systemic inflammatory response of horses subjected to small colon enterotomy and to evaluate heparin effects on postsurgical inflammation. Ten adult horses were subjected to small colon enterotomy and were assigned to a control or a treatment group. Both groups received prophylactic antibiotics and flunixin, and the treatment group received 150 IU/kg heparin subcutaneously after surgery and every 12 hours for five days. WBC counts, peritoneal fluid evaluation, determination of serum and peritoneal haptoglobin (Hp), and serum amyloid A (SAA) were performed before, 12 hours, and 1, 2, 4, 6, 10, and 14 days after enterotomy. Forty-eight hours after surgery, a significant increase in serum Hp was observed in the control group, and SAA concentrations increased significantly in the both groups between 24 hours, 48 hours, and 4 days after surgery. The SAA and serum Hp concentrations produced no significant differences between the groups. Peritoneal Hp increased significantly in the control group 4 days after surgery and was significantly higher in the control group than in the treated group 14 days after surgery. Serum Hp and SAA identified the acute phase response changes faster, however, were not able to identify differences between groups. Peritoneal Hp concentrations identified inflammatory differences between the groups 14 days after surgery; the difference suggests that heparin may act decreasing inflammation.     

A Clinical Trial of Probiotic Administration for Prevention of Salmonella Shedding in the Postoperative Period in Horses With Colic

The purpose of this study was to evaluate the effects of probiotic administration on the prevalence of fecal shedding of Salmonella , the prevalence of postoperative diarrhea, the length of antimicrobial therapy, and the length of the hospitalization stay during the postoperative period in horses with colic. Two commercially available probiotics for horses were used in a double-blind prospective study of 200 horses undergoing surgery for colic. Probiotic or placebo was administered PO once a day for 7 days postoperatively, and fecal cultures for Salmonella were obtained daily for 10 days. After selection of 186 patients completing the treatment protocol, the results indicated that the commercial probiotic formulations had no effect on Salmonella shedding, prevalence of diarrhea, length of antimicrobial therapy, or length of hospitalization ( P > .05). Twenty percent of the horses yielded 1 or more positive fecal cultures for Salmonella; of these horses, 74% were classified as asymptomatic shed-ders. Twenty-six percent of all horses had fluid diarrhea postoperatively, with only 12% of these horses having positive fecal cultures for Salmonella , The most common isolate was Salmonella krefeld (24 of 39 isolates). Among the different gastrointestinal disorders, horses with feed and sand impactions appeared to be more prone to shed Salmonella .     

Effect of Mineral Block Supplementation on In Vivo Digestibility and In Vitro Gas Production With Equine Fecal Bacteria

The effects of a mineral block for horses on in vivo digestibility and in vitro fermentability with equine fecal inoculum were evaluated. Fifty healthy horses from three groups (lactating mares n = 19, working horses n = 18, and maintenance horses n = 13) were randomly assigned to two treatment groups (with or without the mineral block; Ca 10.0%, P 12.0%, Zn 12.1 mg/kg, Cu 2,050 mg/kg, Mn 4,050 mg/kg, Se 30 mg/kg, and I 105 mg/kg). Dry matter digestibility was estimated with an internal marker. Samples of diet were incubated with equine fecal bacteria with varying amounts of mineral block (0, 1.1, 3.6, and 6.2 mg/g dry matter [DM]) to record gas production and to estimate in vitro DM digestibility. The results showed that mineral supplementation with the blocks increased in vivo DM digestibility (P < .01) in all groups, but there was an interaction (P < .01) with a greater response in the maintenance horses (55.5% vs. 78.0%) compared to lactating mares (62.8% vs. 79.6%) and working (70.3% vs. 75.1%). Block consumption was lowest in the lactating mares (12.8 g/d), intermediate in the working horses (44.6 g/d), and highest in the maintenance horses (74.2 g/d). The mineral supplementation did not affect the kinetics of gas production but tended (P = .10) to improve the in vitro DM digestibility (37.01% vs. 38.34%). Mineral block supplementation increased dry matter digestibility in horses. The unsupplemented control diet was deficient in several minerals, and block intake was not proportional to the mineral requirements.     

Psyllium Lowers Blood Glucose and Insulin Concentrations in Horses

A total of 16 mature healthy horses (body weight: 515.3 ± 37 kg [mean ± SD]) were used in two experiments to determine (1) how psyllium affects postprandial blood glucose and insulin concentrations, and (2) how psyllium affects blood glucose and insulin concentrations after an intravenous glucose infusion. Psyllium was fed along with a grain and hay ration (given twice daily) for 60 days. Treatments were as follows: (1) 90 g psyllium/d, (2) 180 g psyllium/d, (3) 270 g psyllium/d, (4) an isocaloric, no supplemental psyllium control. Pre- and postprandial blood samples were collected on day 60 for experiment 1, and blood samples collected before and after intravenous glucose infusion were analyzed for experiment 2. In experiment 1, horses fed with psyllium for 60 days had lower (P < .01) mean postprandial blood glucose concentrations and there was a treatment × time effect for glucose (P < .001) and insulin (P = .03). Plasma glucose was lower at 90 minutes (P = .05) and 120 minutes (P < .001) after a meal in horses fed with psyllium as compared with an isocaloric control. Postprandial serum insulin concentrations were lower at 90 minutes (P = .002) and 300 minutes (P < .001) after a meal in horses fed with psyllium as compared with an isocaloric control. In experiment 2, peak glucose concentrations were lower (P = .01) in horses fed with psyllium for the previous 60 days compared with untreated horses and there was a treatment by time effect for glucose (P = .05). Peak blood glucose response was lower (P = .01) in horses fed with psyllium as compared with an isocaloric control after intravenous glucose infusion, whereas peak insulin concentrations and average insulin concentrations remained similar. Psyllium fed daily for 60 days alters postprandial glycemia and insulinemia in normal, nonobese, and unexercised horses.     

Case-Control Comparison of Cervical Spine Radiographs From Horses With a Clinical Diagnosis of Cervical Facet Disease With Normal Horses

The accuracy of using radiographs to diagnose cervical facet osteoarthritis (CFA) in horses is undetermined. Further investigation is required to determine the clinical significance of radiographic evidence of CFA, the prevalence of radiographic changes in horses without clinical signs, and the long-term efficacy of intra-articular CFA treatment. The objectives of this study is to compare degenerative changes of the cervical facet joints of the cervical vertebrae on radiographs of horses with clinical signs of CFA with healthy cohort-matched horses, to compare clinical findings between groups, and to obtain follow-up information on the long-term outcome in treated horses. This is a retrospective case-control cohort-matched comparison study of horses treated for cervical facet disease versus horses with no clinical signs of cervical facet disease. Horses diagnosed with CFA and treated with intra-articular injection of corticosteroids were included. Follow-up information on recovery from treatment was obtained via telephone survey of owners/trainers. Healthy horses with no clinical signs of CFA were matched to treated horses by breed, sex, age, and sport as the control group. Two blinded radiologists reviewed cervical spine radiographs for each horse and recorded CFA score and intravertebral/intervertebral measurements. Clinical and radiographic parameters were compared between treatment and control groups. There was a significant difference in CFA grades for C5-6 and C6-7 between horses with presence of clinical signs and healthy horses. However, interobserver agreement between radiologists for grading CFA was moderate and only 56% of values were identical for both observers. Atrophy of the neck was present on clinical examination in most cases in the treatment group. Dressage horses were overrepresented. Overall, 64% of horses returned to their previous level of performance after treatment. Clinical examination data collected for the treatment group were retrospective and were obtained by different clinicians. Eight owners/trainers were not able to be reached for the survey. There was a significant difference in CFA grades for C5-6 and C6-7 between horses with presence of clinical signs and healthy horses. Despite these statistical differences, the clinical diagnosis of CFA based on radiographic grading alone is questionable because of the lack of agreement between the radiologists. To strengthen the diagnosis, clinical signs of facet disease, in particular atrophy of the neck muscles, need to be present to make this diagnosis. Intra-articular corticosteroid injection was effective at allowing most treated horses to return to athletic use..     

Pilot Study Investigating Fecal Shedding of Salmonella spp. by Horses Used in Competition

This pilot study was performed to determine the need for future investigation of the effect of transportation, environmental changes, and athletic competition on fecal shedding of Salmonella spp. in sport horses. Fecal samples were collected once daily from 20 healthy horses that were competing in National Collegiate Athletic Association equestrian event that occurred over a 3-day period. The horses were divided into four groups with five horses per group. The groups were divided based on travel distance. Fresh fecal samples were collected daily and cultured for Salmonella spp., through bacterial culture, for a minimum of 3 days for three groups that traveled to compete and for 15 days for a group that was housed at the competition location. All fecal samples were negative for Salmonella spp. Although this was a pilot study with a small sample size and limited collection days, the results of this study question the effects of the stress of transportation, new environment, and athletic activity on fecal shedding of Salmonella spp. in horses. A larger study, however, is needed to further investigate these findings.     

Surgical management of sand colic impactions in horses: a retrospective study of 41 cases

OBJECTIVE: A retrospective review of the medical records of 41 horses requiring abdominal surgery for sand colic. RESULTS: The diagnosis of sand colic was made when sand was found to be the cause of impaction of the gastrointestinal tract during surgical exploration. The most common clinical signs at presentation were abdominal pain, abdominal distension and diarrhoea. A statistically significant association was found between the respiratory rate on arrival and short-term survival. Sand impaction at multiple locations was detected in one-third of the horses. Concurrent pathology was detected in half of the horses. Four horses were euthanased during surgery; of those that recovered from surgery, 35/37 (95%) were discharged from hospital. Short- and long-term complications were similar to those previously reported. Long-term (1 year) survival of the horses discharged was 100%. CONCLUSION: The good prognosis for horses undergoing surgery for the treatment of sand impaction supports early surgical intervention in cases where large amounts of sand are suspected.     

Pharmacokinetics and pharmacodynamics of hydromorphone hydrochloride in healthy horses

ObjectivesTo determine the physiologic and behavioral effects and pharmacokinetic profile of hydromorphone administered intravenously (IV) to horses.Study designProspective, randomized, crossover study.AnimalsA group of six adult healthy horses weighing 585.2 ± 58.7 kg.MethodsEach horse was administered IV hydromorphone (0.025 mg kg^–1; treatment H0.025), hydromorphone (0.05 mg kg^–1; treatment H0.05) or 0.9% saline in random order with a 7 day washout period. For each treatment, physiologic, hematologic, abdominal borborygmi scores and behavioral data were recorded over 5 hours and fecal output was totaled over 24 hours. Data were analyzed using repeated measures anova with significance at p < 0.05. Blood samples were collected in treatment H0.05 for quantification of plasma hydromorphone and hydromorphone-3-glucuronide and subsequent pharmacokinetic parameter calculation.ResultsHydromorphone administration resulted in a dose-dependent increase in heart rate (HR) and systolic arterial pressure (SAP). HR and SAP were 59 ± 17 beats minute^–1 and 230 ± 27 mmHg, respectively, in treatment H0.05 at 5 minutes after administration. No clinically relevant changes in respiratory rate, arterial gases or temperature were observed. The borborygmi scores in both hydromorphone treatments were lower than baseline values for 2 hours. Fecal output did not differ among treatments and no evidence of abdominal discomfort was observed. Recorded behaviors did not differ among treatments. For hydromorphone, mean ± standard deviation for volume of distribution at steady state, total systemic clearance and area under the curve until the last measured concentration were 1.00 ± 0.29 L kg^–1, 106 ± 21 mL minute^–1 kg^–1 and 8.0 ± 1.5 ng hour mL^–1, respectively.Conclusions and clinical relevanceHydromorphone administered IV to healthy horses increased HR and SAP, decreased abdominal borborygmi and did not affect fecal output.     

Investigation on the clinical efficacy and tolerability of a 0.4% topical stannous fluoride preparation (MedEquine Gel) for the treatment of bacterial skin infections in horses: a prospective, randomized, double-blinded, placebo-controlled clinical trial

The purpose of this prospective, double-blinded, placebo-controlled clinical trial was to investigate the efficacy and tolerability of a novel gel containing 0.4% stannous fluoride (MedEquine) for the treatment of cutaneous bacterial infections in horses. Twenty privately owned horses diagnosed with bacterial skin infections based on physical findings and cytology results were enrolled and randomly assigned to either a placebo or an active ingredient treatment group. The product was applied on affected areas daily for 4 weeks. Cytology and clinical evaluations were done by the same investigator at the beginning and at the end of the treatment. Owners scored pruritus weekly. Both owners and investigators were blinded to the allocation to the groups. At the end of the study, stannous fluoride gel treatment significantly decreased the investigator's clinical scores and owners' pruritus scores while no significant changes were detected in the vehicle treatment group. At the end of the trial, none of the horses in the stannous fluoride group required additional therapy while four of ten horses in the vehicle group required systemic therapy to resolve the infection. No adverse effects were detected in any of the groups. The gel formulation made compliance easier for owners compared to the traditional bathing regimen and allowed spot treatment, which was particularly helpful in animals with localized infections. These favourable aspects of the treatment were highlighted by the owners of the horses enrolled in the study. In conclusion, 0.4% stannous fluoride gel (MedEquine) was an effective and safe therapy for the topical management of bacterial skin infections in the horses included in the study.     

Endogenous concentrations,pharmacokinetics, and selected pharmacodynamic effects of a single dose of exogenous GABA in horses

The anti‐anxiety and calming effects following activation of the GABA receptor have been exploited in performance horses by administering products containing GABA. The primary goal of the study reported here was to describe endogenous concentrations of GABA in horses and the pharmacokinetics, selected pharmacodynamic effects, and CSF concentrations following administration of a GABA‐containing product. The mean (±SD) endogenous GABA level was 36.4 ± 12.5 ng/mL (n = 147). Sixteen of these horses received a single intravenous and oral dose of GABA (1650 mg). Blood, urine, and cerebrospinal fluid (n = 2) samples were collected at time 0 and at various times for up to 48 h and analyzed using LC‐MS. Plasma clearance and volume of distribution was 155.6 and 147.6 L/h and 0.154 and 7.39 L for the central and peripheral compartments, respectively. Terminal elimination half‐life was 22.1 (intravenous) and 25.1 (oral) min. Oral bioavailability was 9.81%. Urine GABA concentrations peaked rapidly returning to baseline levels by 3 h. Horses appeared behaviorally unaffected following oral administration, while sedative‐like changes following intravenous administration were transient. Heart rate was increased for 1 h postintravenous administration, and gastrointestinal sounds decreased for approximately 30 min following both intravenous and oral administration. Based on a limited number of horses and time points, exogenously administered GABA does not appear to enter the CSF to an appreciable extent.     

Comparative long-term efficacy of ivermectin and moxidectin over winter in Canadian horses treated at removal from pastures for winter housing

The impact of a late fall treatment on the spring rise of fecal egg counts was evaluated in a controlled study with Canadian horses treated with 2 different dewormers immediately after removal from pasture for winter housing. The horses were stabled until the end of the trial period. Seventeen weanlings, 20 yearlings, and 15 2-year-old horses located in Ontario, which were presumed to be naturally infected with cyathostomins after pasture grazing, were randomly allocated to either a group treated with 0.4 mg/kg of moxidectin and 2.5 mg/kg of praziquantel or a group treated with 0.2 mg/kg of ivermectin and 1.5 mg/kg of praziquantel. Three weeks after treatment, all strongyle fecal egg counts were reduced to zero for both treatment groups. However, at 5 months post-treatment, mean geometric fecal egg counts were statistically higher for the yearlings and 2-year-old horses treated with ivermectin than for the yearlings and 2-year-old horses treated with moxidectin (P < 0.0001).